zoom_in
Click to enlarge
description Viatris (VTRS) Overview
Viatris is a global pharmaceutical company focused on generic drugs and biosimilars. The company offers a relatively high dividend yield, making it attractive to income-seeking investors. Viatris faces challenges from pricing pressure and competition in the generic drug market. The current dividend yield is approximately 4.8%.
help Viatris (VTRS) FAQ
What is Viatris (VTRS)?
Viatris is a global pharmaceutical company focused on generic drugs and biosimilars. The company offers a relatively high dividend yield, making it attractive to income-seeking investors. Viatris faces challenges from pricing pressure and competition in the generic drug market. The current dividend yield is approximately 4.8%.
How good is Viatris (VTRS)?
Viatris (VTRS) scores 7.1/10 (Good) on Lunoo, making it a well-rated option in the Dividend Stocks category.
What are the best alternatives to Viatris (VTRS)?
See our alternatives page for Viatris (VTRS) for a ranked list with scores. Top alternatives include: ExxonMobil (XOM), Johnson & Johnson (JNJ), NextEra Energy (NEE).
How does Viatris (VTRS) compare to ExxonMobil (XOM)?
See our detailed comparison of Viatris (VTRS) vs ExxonMobil (XOM) with scores, features, and an AI-powered verdict.
Is Viatris (VTRS) worth it in 2026?
With a score of 7.1/10, Viatris (VTRS) is a solid option in Dividend Stocks. See all Dividend Stocks ranked.
explore Explore More
Similar to Viatris (VTRS)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
